TLRY vs USNA
Tilray Brands, Inc. and Usana Health Sciences Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | TLRY | USNA |
|---|---|---|
| Revenue | $915.5M | $925.3M |
| Net income | $-121.4M | $10.8M |
| Gross margin | 28.4% | 78.3% |
| Net margin | −11.5% | 1.2% |
| Return on equity | −7.8% | 2.0% |
| Diluted EPS | −$1.09 | $0.58 |
| Dividend / share | · | · |
| Payout ratio | · | · |
| Free cash flow | · | $8.5M |
| Equity | $1.6B | $533.1M |
| Net debt / equity | −0.13× | · |
| Current ratio | 2.21× | 2.24× |
| Revenue CAGR 5y | 12.3% | −4.0% |
| Profit CAGR 5y | · | −38.7% |
TLRY and USNA book revenue within 15% of each other, and TLRY closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | TLRY | USNA |
|---|---|---|
| FY2025 | $915.5M | $925.3M |
| FY2024 | $821.3M | $854.5M |
| FY2023 | $788.9M | $921.0M |
| FY2022 | $627.1M | $998.6M |
| FY2021 | $628.4M | $1.2B |
| FY2020 | $513.1M | $1.1B |
| FY2019 | $405.3M | $1.1B |
| FY2018 | $179.3M | $1.2B |
| FY2017 | $20.5M | $1.0B |
| FY2016 | $12.6M | $1.0B |
Bottom line
| Fiscal year | TLRY | USNA |
|---|---|---|
| FY2025 | $-121.4M | $10.8M |
| FY2024 | $-2.2B | $42.0M |
| FY2023 | $-245.0M | $63.8M |
| FY2022 | $-1.5B | $69.3M |
| FY2021 | $-476.8M | $116.5M |
| FY2020 | $-367.4M | $124.7M |
| FY2019 | $-102.5M | $100.5M |
| FY2018 | $-25.0M | $126.2M |
| FY2017 | $-7.8M | $62.5M |
| FY2016 | $-7.9M | $100.0M |
10 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −$9,803,000 | USNA |
| FY2024 | −$33,194,000 | USNA |
| FY2023 | −$132,068,000 | USNA |
| FY2022 | −$371,477,000 | USNA |
| FY2021 | −$558,092,000 | USNA |
| FY2020 | −$621,559,000 | USNA |
| FY2019 | −$655,576,000 | USNA |
| FY2018 | −$1,009,945,000 | USNA |
| FY2017 | −$1,026,727,000 | USNA |
| FY2016 | −$993,439,000 | USNA |
USNA has reported the higher revenue in every one of these 10 fiscal years. The gap has narrowed since the earliest year compared.
10 of 17 comparable fiscal years — a year missing data on either side is not counted.
10 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −12.7 pp | USNA |
| FY2024 | −270.5 pp | USNA |
| FY2023 | −35.1 pp | USNA |
| FY2022 | −237.0 pp | USNA |
| FY2021 | −78.9 pp | USNA |
| FY2020 | −76.5 pp | USNA |
| FY2019 | −34.4 pp | USNA |
| FY2018 | −30.7 pp | USNA |
| FY2017 | −44.0 pp | USNA |
| FY2016 | −72.3 pp | USNA |
USNA has kept the higher net margin in every one of these 10 fiscal years.
10 of 17 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
TLRY's net margin has been more volatile than USNA's over the 10 comparable fiscal years — 85.6 percentage points of standard deviation against 2.9.
10 of 17 comparable fiscal years — a year missing data on either side is not counted.
Year by year
USNA led in net margin in every one of the 10 comparable fiscal years — a structural lead, not a recent swing.
10 of 17 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
TLRY's return on equity has been more volatile than USNA's over the 8 comparable fiscal years — 98.1 percentage points of standard deviation against 10.8.
8 of 17 comparable fiscal years — a year missing data on either side is not counted.
Year by year
USNA led in return on equity in every one of the 8 comparable fiscal years — a structural lead, not a recent swing.
8 of 17 comparable fiscal years — a year missing data on either side is not counted.